ARCHIVES

The Clinical Trials Working Group: NCI panel considers plan to centralize clinical trial review and prioritization. NCI director faults system for duplication, “equivocal results.”

This article is from The Cancer Letter archive.

Vol. 30 No. 33 | August 13, 2004

Download PDF Visit The Full Archive

Related Articles

Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease

November 30, 2012

Funding Opportunities Listed.

January 14, 2005

Ohio State, Hawaii Name New Center Directors; Berlin Acting Director At Papanicolaou

July 29, 1988

COG Begins Phase III Trial To Prevent Hearing Loss

May 30, 2008

Obey Erred On Criticism Of Pap Test Cost, FCRC Construction

August 10, 1979

Spectral Mammography “Like Color vs. Black & White TV”

August 31, 2012